4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-031014
SVP, COO & CFO sold 7,727 shares at an average $22.54 ($174,155)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2020-05-18 | Sale | −5,727 | $22.51 | $128,915 | 247,494 | D: show line 1 in the form |
| Labrucherie Gil M SVP, COO & CFO | 2020-05-19 | Sale | −2,000 | $22.62 | $45,240 | 245,494 | D: show line 2 in the form |
| Open-market sales · 7,727 sh · avg $22.54 · $174,155 | |||||||
Loading xslF345X03/doc4.xml…